In our post of June 10 we mentioned that Renhuang Pharmaceuticals (RHGP) was almost ready for uplisting to AMEX. Yesterday they announced that they received approval to list its common stock on the NYSE Amex.
Renhuang expects to begin trading on the NYSE Amex on Friday, July 2, 2010. In connection with the listing on NYSE Amex, Renhuang's stock symbol will change to "CBP" from "RHGP".
"We are very pleased to move onto the NYSE Amex and begin our next phase as a public company," said Mr. Shaoming Li, Chairman of the Board, Chief Executive Officer and President of Renhuang Pharmaceuticals, Inc. "We are honored to join the family of NYSE companies and this is an important milestone in our continuous efforts to raise our profile within the investment community, improve our stock's liquidity, expand our transparency and enhance our corporate governance."
A positive step in the right direction to become an major player in the market of botanical products, bio-pharmaceuticals and traditional Chinese medicines.